Medical Devices

June 08, 2023

Buy ($175)

Companies covered: Medtronic, Inc. (NYSE:MDT), Stryker Corporation (NYSE:SYK), Intuitive Surgical, Inc. (NASDAQ:ISRG), GE HealthCare Technologies Inc. (NASDAQ:GEHC), Johnson & Johnson (NYSE:JNJ), Globus Medical, Inc. (NYSE:GMED), NuVasive, Inc. (NASDAQ:NUVA), Orthofix International N.V. (NASDAQ:OFIX), Abbott Laboratories (NYSE:ABT), Zimmer Biomet Holdings Inc. (NYSE:ZBH), Penumbra Inc. (NYSE:PEN), Treace Medical Concepts Inc. (NASDAQ:TMCI), Avita Medical Inc. (NASDAQ:RCEL), LENSAR Inc. (NASDAQ:LNSR), Humacyte Inc. (NASDAQ: HUMA), DexCom, Inc. (NASDAQ:DXCM), Boston Scientific Corporation (NYSE:BSX), RxSight Inc. (NASDAQ:RXST), Integra LifeSciences Holdings Corporation (NASDAQ:IART), P3 Healthcare Partners Inc. (NASDAQ:PIII), Apollo Medical Holdings, Inc. (NASDAQ:AMEH), Viemed Healthcare Inc. (NASDAQ:VMD), InfuSystems Holdings, Inc. (NYSEAMERICAN:INFU), iCAD, Inc. (NASDAQ:ICAD), Augmedix Inc. (NASDAQ:AUGX), Alphatec Holdings, Inc. (NASDAQ:ATEC), Harrow Health Inc. (NASDAQ:HROW), Tandem Diabetes Care, Inc. (NASDAQ:TNDM), Modivcare Inc. (NASDAQ:MODV), Smith & Nephew SNATS, Inc. (NYSE:SNN), IDEXX Laboratories, Inc. (NASDAQ:IDXX), Hologic, Inc. (NASDAQ:HOLX), Siemens AG (OTCMKTS:SIEGY), Zoetis Inc. (NYSE:ZTS), Illumina, Inc. (NASDAQ:ILMN), Clearpoint Neuro Inc. (NASDAQ:CLPT), Xtant Medical Holdings Inc. (NYSEAMERICAN:XTNT), Materialise NV (NASDAQ:MTLS)